Ensemble Therapeutics Corporation ' Product Pipeline Review ' 2012

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Ensemble Therapeutics Corporation ' Product Pipeline Review ' 2012
Published on December 2012

Report Summary


Summary

Global Market Direct's pharmaceuticals report, "Ensemble Therapeutics Corporation - Product Pipeline Review - 2012" provides data
on the Ensemble Therapeutics Corporation's research and development focus. The report includes information on current
developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Ensemble Therapeutics
Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Ensemble Therapeutics
Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Ensemble Therapeutics Corporation - Brief Ensemble Therapeutics Corporation overview including business description, key
information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ensemble Therapeutics Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities,
across the globe.
- Product profiles for late stage and clinical stage products of Ensemble Therapeutics Corporation with complete description of the
product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Ensemble Therapeutics Corporation's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Ensemble Therapeutics Corporation's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Ensemble Therapeutics Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Ensemble Therapeutics Corporation's R&D portfolio and develop key
strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Ensemble Therapeutics Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Ensemble Therapeutics Corporation and identify potential opportunities in those
areas.

Ensemble Therapeutics Corporation ' Product Pipeline Review ' 2012 (From Slideshare) Page 1/6


Table of Content

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ensemble Therapeutics Corporation Snapshot 5
Ensemble Therapeutics Corporation Overview 5
Key Information 5
Key Facts 5
Ensemble Therapeutics Corporation ' Research and Development Overview 6
Key Therapeutic Areas 6
Ensemble Therapeutics Corporation ' Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products ' Monotherapy 9
Ensemble Therapeutics Corporation ' Pipeline Products Glance 10
Ensemble Therapeutics Corporation ' Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Ensemble Therapeutics Corporation ' Drug Profiles 12
Drug 1 For Inflammation 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Drug 2 For Inflammation 13
R&D Progress 13
Drug For Diabetes 14
R&D Progress 14
Drug For Oncology 15
R&D Progress 15
Drug For Pain 16
R&D Progress 16
Interleukin-17 Antagonist 17
R&D Progress 17
Ensemble Therapeutics Corporation ' Pipeline Analysis 18
Ensemble Therapeutics Corporation ' Pipeline Products by Therapeutic Class 18



Ensemble Therapeutics Corporation ' Pipeline Products by Route of Administration 19
Ensemble Therapeutics Corporation ' Pipeline Products By Mechanism of Action 20
Ensemble Therapeutics Corporation ' Recent Pipeline Updates 21
Ensemble Therapeutics Corporation ' Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Ensemble Therapeutics Corporation, Recent Developments 23
Ensemble Therapeutics Corporation- Press Release 23
Nov 12, 2012: Ensemble Therapeutics Presents Oral Efficacy Of Small Molecule Targeting IL-17 For Inflammation In Preclinical
Studies 23
Oct 29, 2012: Ensemble Therapeutics To Present Poster On Interleukin-17 At 2012 ACR Annual Meeting 24
Financial Deals Landscape 25
Ensemble Therapeutics Corporation, Deals Summary 25
Ensemble Therapeutics Corporation, Pharmaceuticals & Healthcare, Deal Details 26
Partnerships 26
Ensemble Therapeutics Enters Into Drug Discovery Agreement With Boehringer Ingelheim 26
Ensemble Therapeutics Enters Into Drug Discovery Agreement With Genentech 28
Ensemble Therapeutics Extends Co-Development Agreement With Bristol-Myers Squibb 29
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables

Ensemble Therapeutics Corporation, Key Information 5
Ensemble Therapeutics Corporation, Key Facts 5
Ensemble Therapeutics Corporation ' Pipeline by Indication, 2012 7
Ensemble Therapeutics Corporation ' Pipeline by Stage of Development, 2012 8
Ensemble Therapeutics Corporation ' Monotherapy Products in Pipeline, 2012 9
Ensemble Therapeutics Corporation ' Pre-Clinical, 2012 10
Ensemble Therapeutics Corporation ' Discovery, 2012 11
Ensemble Therapeutics Corporation ' Pipeline By Therapeutic Class, 2012 18
Ensemble Therapeutics Corporation ' Pipeline By Route of Administration, 2012 19
Ensemble Therapeutics Corporation ' Pipeline Products By Mechanism of Action, 2012 20
Ensemble Therapeutics Corporation ' Recent Pipeline Updates, 2012 21
Ensemble Therapeutics Corporation, Other Locations 22
Ensemble Therapeutics Corporation, Deals Summary 25
Ensemble Therapeutics Enters Into Drug Discovery Agreement With Boehringer Ingelheim 26
Ensemble Therapeutics Enters Into Drug Discovery Agreement With Genentech 28
Ensemble Therapeutics Extends Co-Development Agreement With Bristol-Myers Squibb 29



List of Figures

Ensemble Therapeutics Corporation ' Pipeline by Indication, 2012 7
Ensemble Therapeutics Corporation ' Pipeline by Stage of Development, 2012 8
Ensemble Therapeutics Corporation ' Monotherapy Products in Pipeline, 2012 9
Ensemble Therapeutics Corporation - Pipeline Products By Mechanism of Action, 2012 20


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 1 500.00 Quantity: _____

Site License--USD 3 000.00 Quantity: _____

Corporate License--USD 4 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Ensemble Therapeutics Corporation ' Product Pipeline Review ' 2012

Recomendados

Recomendados

Más contenido relacionado

Más de ReportLinker.com

Más de ReportLinker.com (20)

Ensemble Therapeutics Corporation ' Product Pipeline Review ' 2012